Gates Foundation Commits $1 Billion to Expand AI Access
Sep 17, 2026
Healthcare
ProFound Gets Gates Foundation Investment for AI Maternal Health Research
Aug 27, 2026
ProFound Therapeutics has received an investment commitment of up to $35 million from the Gates Foundation to support AI based research into preeclampsia and eclampsia.
ProFound Therapeutics has received an investment commitment of up to $35 million from the Gates Foundation, including an initial $20 million, to support AI based research into preeclampsia and eclampsia, the company announced in a press release.
The funding will support ProFound Therapeutics' ProFoundry platform and agentic AI capabilities. The company plans to use the platform to identify new biomarkers, protein drugs, and drug targets linked to preeclampsia and eclampsia.
ProFound will study proteins from the expanded human proteome that are expressed in placenta and serum samples from women with the conditions. The work also includes creation of an AI tool specific to preeclampsia and eclampsia.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Enterprise AI Brief or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 Intuit Agrees to Acquire AI Billing Startup Sequence for Reported $200 Million Oct 16 Matters Raises $5 Million to Build AI Consumer Bank Oct 16 KP Labs raises €4.42 million for AI data processing in orbit Oct 15 Origin Raises $20 Million for Autonomous Construction Robots Oct 15 Symbe Raises $5.7 Million for AI Sales PlatformMore from Enterprise
Oct 16 BOC Group Adds AI Assistant to ADOIT 21 Oct 16 Huawei Brings Upgraded Stellar Network Solution to Europe Oct 16 Element to Manage Waymo's Toronto Fleet for 2028 Launch Oct 16 CTM and Huawei Plan AI Network Security Upgrades in Macao Oct 16 Huawei and 14 partners form Global AI CITY allianceFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Sep 24, 2026
Funding
Expanse Raises $5.3 Million for AI Compute Planning Software
Sep 17, 2026
Data Centers
INmune Bio and QCi Apply Quantum Computing to XPro Research
Oct 14, 2026
Life Sciences
ARPA-H Funds $28.6 Million AI Protein Research Project
Oct 12, 2026
Biotech
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
Oct 14, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.